HIV/AIDS: vaccines and alternate strategies for treatment and prevention.
The symposium "HIV/AIDS: Vaccines and Alternate Strategies for Treatment and Prevention" brought together HIV vaccine researchers to discuss the latest developments in the field. From basic discoveries in virus diversity and mechanisms of neutralization by antibodies to nonhuman primate research and clinical trials of vaccine candidates in volunteers, scientists are making great strides in understanding the mechanisms that may protect against HIV and pathways to achieve this protection through vaccination.
Voronin
Yegor
Y
Global HIV Vaccine Enterprise, New York, New York, USA. yvoronin@vaccineenterprise.org
Phogat
Sanjay
S
D016915:AIDS Vaccines / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use; D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control* / Q000628:therapy*; D000818:Animals; D057134:Antibodies, Neutralizing / Q000276:immunology / Q000302:isolation & purification; D002986:Clinical Trials as Topic; D006678:HIV / Q000235:genetics / Q000276:immunology*; D015483:HIV Antibodies / Q000276:immunology / Q000302:isolation & purification; D015658:HIV Infections / Q000517:prevention & control* / Q000628:therapy*; D006801:Humans; D007391:International Cooperation; D015302:Simian Immunodeficiency Virus / Q000235:genetics / Q000276:immunology; D014616:Vaccinia virus / Q000235:genetics / Q000276:immunology; D054299:env Gene Products, Human Immunodeficiency Virus / Q000737:chemistry / Q000276:immunology
D016915:AIDS Vaccines; D057134:Antibodies, Neutralizing; D015483:HIV Antibodies; D054299:env Gene Products, Human Immunodeficiency Virus